Table 2

Correlation of ESSPRI with clinical parameters in the whole cohort

ESSPRI versus clinical parametersSjS
(n=172)
Sicca
(n=145)
Β
(95% CI)
P valueΒ
(95% CI)
P value
Age0.01
(−0.02 to 0.4)
0.37−0.01
(−0.04 to 0.03)
0.60
HADS A0.15
(0.07 to 0.23)
<0.00010.1
(0.02 to 0.2)
0.02
HADS D0.16
(0.07 to 0.26)
0.0010.24
(0.14 to 0.34)
<0.0001
BMI0.1
(0.005 to 0.15)
0.040.1
(0.06 to 0.18)
<0.0001
Schirmer’ s test−0.03
(−0.07 to 0.13)
0.170.02
(−0.01 to 0.05)
0.24
Unstimulated salivary flow−0.2
(-0.73 to 0.37)
0.51−0.5
(-0.92 to 0.12)
0.01
C31.8
(0.22 to 3.6)
0.032.5
(0.89 to 4)
0.002
C40.6
(−0.16 to 0.24)
0.645.2
(0.72 to 9.78)
0.02
IgG−0.01
(−0.06 to 0.04)
0.960.02
(-0.11 to 0.15)
0.79
K/L free light chain quotient−0.2
(−0.62 to 0.20)
0.310.3
(−0.55 to 1.11)
0.51
CRP0.01
(−0.11 to 0.13)
0.850.07
(−0.03 to 0.16)
0.17
  • Values shown are the linear regression unstandardised coefficients and 95% CIs.

  • P values <0.05 marked in bold.

  • BMI, body mass index; CRP, C reactive protein; ESSPRI, EULAR Sjögren’s Syndrome Patient-Reported Index; HADS, Hospital Anxiety and Depression Scale; SjS, Sjogren’s syndrome.